Tag: DVAX News

Business

Dynavax Technologies Corporation (NASDAQ: DVAX) and Biological E enter into a Commercial Supply Agreement of Dynavax’s CpG 1018 Advanced Adjuvant

by 0 comments

With the uncertainty caused by the COVID-19 pandemic, many institutions have had to refocus to ensure they are only investing in critical business areas. Dynavax Technologies Corporation (Nasdaq: DVAX) is one of those that has acted quickly to safeguard the health and safety of its employees and customers. And in […]

Continue Reading →
Business

Cerus Corporation (NASDAQ: CERS) Announces Partnership with LifeSouth Community Blood Centers to produce INTERCEPT® Fibrinogen Complex

by 0 comments

Cerus Corporation (NASDAQ: CERS) announced today an arrangement with LifeSouth Community Blood Centers to aid as a creative associate for INTERCEPT® Fibrinogen Complex, the company’s pathogen abridged cryoprecipitate fibrinogen multifaceted creation.  LifeSouth is the fifth manufacture associate for INTERCEPT Fibrinogen Complex LifeSouth is the fifth manufacture associate for INTERCEPT Fibrinogen […]

Continue Reading →